John G. Shields

Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Serentis, Inc. provides biopharmaceutical products. The company discovers, develops and commercializes medicinal products. It is headquartered in Dover, DE.

Safeway Ltd. owns and operates a chain of supermarkets. The company was incorporated on February 23, 1977 and is headquartered in Hayes, the United Kingdom.

Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022.

Part of EXEL Industries SA, Rasindeck Ltd. is a British company founded in 1998 that provides a new soft-touch lightweight woven hose called Wonderhoze. The company is based in Sutton Coldfield, UK and offers gardening solutions to help gardens flourish and come to life. The hose is designed to provide comfort when watering and is compact and flexible, expanding up to 3 times its original length. The key benefits of Wonderhoze include a strong soft-touch woven fabric layer, guaranteed leak-free fittings, and a water-tight connection. Hozelock, the parent company, combines a knowledge and passion for gardening, and pride in product craftsmanship.

Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom.

Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA

Part of EXEL Industries SA, Thistlehaven Ltd. operates as a holding British company. The company is based in Sutton Coldfield, UK.

The Clinical Force team has significant experience of both Pharmaceutical / Biotechnology companies and CROs. Clinical Force's main aim is to remove the barriers of technology adoption within the Life science industry. The main barriers to technology adoption have been: Expense of installing a solution Inflexibility of solutions Difficulty of installation and use of solutions The Clinical Force solutions were developed in collaboration with a number of Life Science companies, and are focused on Clinical process improvement. The Clinical Force solutions are aimed at small to medium sized Life Science organizations that are looking to improve current clinical processes by the adoption of cost effective and easy to use applications. The Clinical Force team comes from a background in software development and system integration in the Life Science industry. Clinical Force is a pure play Clinical Trials Management Company, they don't do EDC or any other technologies because: oThe user bases are different oThe deployments are different oThey believe in best of breed solutions - they specialize oThe CTMS market is very broad and requires full attention They bring together the best of software development, consultancy and strong industry experience including CRO, biotechnology and Pharmaceutical companies. In addition to their own development team Clinical Force works closely with industry advisers who are active at both VP/Management level and Clinical Operations in Pharmaceutical and CROs. They listen to their customers, they understand their challenges, and they develop innovative solutions to address these challenges. Their purpose is to build world class software that helps organizations such as customers achieve and exceed customer's goals.

Dentsu International Ltd. engages in the provision of media advertising and digital communications services. It offers digital creative execution, content creation, media planning, sports, entertainment marketing and search engine optimization strategy, near-field communications, and marketing analytics. The company was founded on December 5, 1978 and is headquartered in London, the United Kingdom.

Part of Watkin Jones Plc, Watkin Jones Group Ltd. is a British company that develops building projects. The company is based in Bangor, UK. The company was founded in 1791 by Huw Jones. Mark Watkin Jones has been the CEO of the company since 2003.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom.

Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom.

Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom.

Abingworth Bioventures GP Ltd. provides marine cargo handling facilities. The company was founded on March 29, 2012 and is headquartered in London, the United Kingdom.

Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases.

Entact Bio, Inc. is a company that focuses on creating new medicines by enhancing protein function. The company is based in Watertown, MA. The company is a team of scientists, entrepreneurs, drug creators, and problem solvers who work together to bring new medicines to patients who currently have few options. The CEO of the company is Victoria M. Richon. The founder of the company grew up in chaos and instability in an undisclosed capital city and has always been passionate and motivated to help enhance and provide medical solutions.